Combination of artificial intelligence endoscopic diagnosis and Kimura‐Takemoto classification determined by endoscopic experts may effectively evaluate the stratification of gastric atrophy in post‐eradication status
Open Access
Abstract
Background: Since it is difficult for expert endoscopists to diagnose early gastric cancer in post‐eradication status, it may be critical to evaluate the stratification of high‐risk groups using the advance of gastric atrophy or intestinal metaplasia. We tried to determine whether the combination of endoscopic artificial intelligence (AI) diagnosis for the evaluation of gastric atrophy could be a useful tool in both pre‐ and post‐eradication status.Methods: 270 Helicobacter pylori‐positive outpatients (Study I) were enrolled and Study II was planned to compare patients (n = 72) with pre‐eradication therapy with post‐eradication therapy. Assessment of endoscopic appearance was evaluated by the Kyoto classification and Kimura‐Takemoto classification. The trained neural network generated a continuous number between 0 and 1 for gastric atrophy.Results: There were significant associations between the severity of gastric atrophy determined by AI endoscopic diagnosis and not having a regular arrangement of collecting venules in angle, visibility of vascular pattern, and mucus using Kyoto classification in H. pylori‐positive gastritis. There were significant differences (p = 0.037 and p = 0.014) in the severity of gastric atrophy between the high‐risk group and low‐risk group based on the combination of Kimura‐Takemoto classification and endoscopic AI diagnosis in pre‐ and post‐eradication status. The area under the curve values of the severity of gastric atrophy (0.674) determined by the combination of Kimura‐Takemoto classification and gastric atrophy determined by AI diagnosis was higher than that determined by Kimura‐Takemoto classification alone in post‐eradication status.Conclusion: A combination of gastric atrophy determined by AI endoscopic diagnosis and Kimura‐Takemoto classification may be a useful tool for the prediction of high‐risk groups in post‐eradication status.Keywords
This publication has 23 references indexed in Scilit:
- Kyoto global consensus report onHelicobacter pylorigastritisGut, 2015
- Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapyGastric Cancer, 2015
- Endoscopic diagnosis of gastric mucosal atrophy: Multicenter prospective studyDigestive Endoscopy, 2014
- The corpus‐predominant gastritis index may serve as an early marker of Helicobacter pylori‐infected patients at risk of gastric cancerAlimentary Pharmacology & Therapeutics, 2013
- Gastritis OLGA‐staging and gastric cancer risk: a twelve‐year clinico‐pathological follow‐up studyAlimentary Pharmacology & Therapeutics, 2010
- Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patientsGut, 2006
- Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9‐year prospective follow‐up study in JapanAlimentary Pharmacology & Therapeutics, 2005
- Helicobacter pylori‐induced enlarged‐fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinomaJournal of Gastroenterology and Hepatology, 2003
- Helicobacter pyloriInfection and the Development of Gastric CancerNew England Journal of Medicine, 2001
- Gastric carcinoma risk index in patients infected with Helicobacter pyloriVirchows Archiv, 1998